» Articles » PMID: 18672116

Impact of Immediate Postabortal Insertion of Intrauterine Contraception on Repeat Abortion

Overview
Journal Contraception
Publisher Elsevier
Date 2008 Aug 2
PMID 18672116
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Of the 1.3 million abortions performed annually in the United States, approximately half are repeat procedures. Immediate postabortal intrauterine device (IUD) insertion is a safe, effective, practical and underutilized intervention that we hypothesize will significantly decrease repeat unintended pregnancy and abortion.

Study Design: All women receiving immediate postabortal IUD insertion in eight clinics of a Northern California Planned Parenthood agency during a 3-year period comprise the IUD cohort. We selected a cohort of controls receiving abortions but choosing other, non-IUD contraception on the day of the abortion visit in a 2:1 ratio matched by date of abortion. We obtained follow-up data on repeat abortions within the agency for both cohorts through 14 months after the 3-year period. We evaluated differences in repeat abortion between cohorts. All analyses were intent-to-treat.

Results: Women who received an immediate postabortal IUD had a lower rate of repeat abortions than controls (p<.001). Women who received a postabortal IUD had 34.6 abortions per 1000 woman-years of follow-up compared to 91.3 for the control group. The hazard ratio for repeat abortion was 0.38 [95% confidence interval (CI), 0.27-0.53] for women receiving a postabortal IUD compared to controls. When adjusted for age, race/ethnicity, marital status, and family size, the hazard ratio was 0.37 (95% CI, 0.26-0.52).

Conclusion: Immediate postabortal intrauterine contraception has the potential to significantly reduce repeat abortion.

Citing Articles

Immediate and delayed placement of the intrauterine device after abortion: a systematic review and meta-analysis.

Lou Y, Tang S, Sheng Z, Lian H, Yang J, Jin X Sci Rep. 2024; 14(1):11385.

PMID: 38762680 PMC: 11102502. DOI: 10.1038/s41598-024-62327-1.


Expanding community pharmacists' scope of practice in relation to contraceptive counselling and referral: a protocol for a pragmatic, stepped-wedge, cluster randomised trial (ALLIANCE).

Mazza D, Assifi A, Hussainy S, Bateson D, Johnston S, Tomnay J BMJ Open. 2023; 13(8):e073154.

PMID: 37652588 PMC: 10476139. DOI: 10.1136/bmjopen-2023-073154.


Socio-demographic and reproductive characteristics of clients that accepted contraceptives at abortion center at the Charlotte Maxeke Johannesburg Academic Hospital (CMJAH), Johannesburg, South Africa: a cross-sectional study (January-July 2021).

Baffour-Duah K, Shimange-Matsose L, Olorunfemi G Pan Afr Med J. 2023; 45:39.

PMID: 37545609 PMC: 10403766. DOI: 10.11604/pamj.2023.45.39.37441.


Safety of voluntary interruption of pregnancy (VIP) in two healthcare institutions in Medellín, Colombia, in 2019. Historical cohort.

Cardenas-Arias E, Escudero-Cardona D, Norena-Mosquera E Rev Colomb Obstet Ginecol. 2022; 73(1):39-47.

PMID: 35503301 PMC: 9084360. DOI: 10.18597/rcog.3760.


Predictors and Barriers to Post Abortion Family Planning Uptake in Hai District, Northern Tanzania: A Mixed Methods Study.

Asubiojo B, Ngwamkai P, Shayo B, Mwangi R, Mahande M, Msuya S East Afr Health Res J. 2022; 5(2):182-192.

PMID: 35036846 PMC: 8751482. DOI: 10.24248/eahrj.v5i2.671.